These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1824972)

  • 1. Prolongation of mouse skin allograft survival by cloned veto suppressor cells.
    Takahashi T; Maki T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):192-3. PubMed ID: 1824972
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo activities of long-term cultured veto suppressor clones.
    Yanagie H; Takeda Y; Maki T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):350-1. PubMed ID: 8438330
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
    Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
    Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of suppressor cells and allograft tolerance.
    Brent L; Horsburgh T; Wood PJ
    Transplant Proc; 1980 Sep; 12(3):464-72. PubMed ID: 6452724
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of skin allograft survival in ATS-treated mice by post-transplant injections of species antigenic extracts.
    Chutná J; Sládecek M; Holán V; Hasek M
    Folia Biol (Praha); 1984; 30(2):109-22. PubMed ID: 6233181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of suppressor cells in the blood transfusion phenomenon.
    Singh SK; Marquet RL; de Bruin RW; Westbroek DL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1442-4. PubMed ID: 2978878
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
    Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
    Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
    Brondz BD; Kazansky DB; Chernyshova AD; Ivanov VS
    Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 16. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responsiveness following skin grafting in cyclosporine-treated rats.
    Towpik E; Kupiec-Weglinski JW; Uhteg LC; Padberg W; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):497-8. PubMed ID: 2978916
    [No Abstract]   [Full Text] [Related]  

  • 18. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are DST/allograft-induced suppressor cells donor specific?
    Wakely E; Cutkomp J; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):488-90. PubMed ID: 2523147
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity requirement of donor bone marrow cells that prolong allograft survival: implications for a veto cell mechanism of action.
    De Fazio SR; Markees TG; Hartner WC; Gozzo JJ
    Transplant Proc; 1995 Feb; 27(1):171-3. PubMed ID: 7878960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.